News Announcement

Caplin Point Laboratories: Board Meeting Outcome for Outcome Of Board Meeting

we wish to inform you that the Board of Directors at its meeting held today has inter-alia approved the following:1. Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31 2023.2. Fixed June 9 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend.3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31 2023 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).4.Further the Nomination and Remuneration Committee of the Board of Directors of the Company has allotted 12 000 equity shares of face value Rs. 2/- each to the employees of the Company upon exercise of stock options under Employee Stock Options Scheme(s) of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds